Evaluating the efficacy of acupuncture versus beconase in the treatment of allergic rhinitis - Beconase v acupuncture

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-000947-24-GB

Enrollment

Registered

2006-03-28

Start date

2006-04-20

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Trade Name: beclamethasone Diproprionate aqueous nasal spray Pharmaceutical Form: Nasal spray* INN or Proposed INN: Beclomethasone Diproprionate CAS Number: 5534-09--8 Current Sponsor code: R&D2005/12

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis of allergic rhinitis Aged 18-65 Positive skin prick allergy test Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Needle phobia

Design outcomes

Primary

Measure	Time frame
Main Objective: To ascertain the eficcacy of acupuncture versus beclamethasone in alergic rhinitis;Secondary Objective: ;Primary end point(s): recurrence of allergic rhinitis	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026